Fifty years of pancreas cancer care Review


Authors: Brennan, M. F.; Allen, P. J.; Jarnagin, W. R.
Review Title: Fifty years of pancreas cancer care
Abstract: Resulting from 50 years of innovation, operations for pancreatic neoplasms can now be performed safely, albeit with significant but manageable morbidity. Molecular diagnosis has allowed for the identification of multiple distinct histopathologies with variable natural histories. Observation is now a strategy for selected indolent cysts and some neuroendocrine neoplasms. For ductal pancreatic adenocarcinoma, a long-term cure remains elusive and will require more than surgical resection for meaningful progress. © 2022 Wiley Periodicals LLC.
Keywords: cancer chemotherapy; treatment outcome; treatment response; cancer surgery; histopathology; advanced cancer; pancreas cancer; neoadjuvant therapy; pancreatic neoplasms; antineoplastic agent; cancer diagnosis; adenocarcinoma; pancreas; pancreas cyst; carcinoma, pancreatic ductal; pathology; cancer therapy; neuroendocrine tumor; pancreas carcinoma; total quality management; pancreas tumor; long term care; pancreas adenocarcinoma; surgery; clinical observation; neuroendocrine tumors; history of medicine; pancreas islet cell tumor; randomized controlled trial (topic); molecular diagnosis; minimally invasive procedure; pancreas surgery; cancer; humans; human; article
Journal Title: Journal of Surgical Oncology
Volume: 126
Issue: 5
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2022-10-01
Start Page: 876
End Page: 880
Language: English
DOI: 10.1002/jso.27030
PUBMED: 36087087
PROVIDER: scopus
PMCID: PMC9469554
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan
  2. William R Jarnagin
    903 Jarnagin